R&D Discussion in New York City to Review IL-12’s Potential to Treat Ovarian Cancer Program Features Ovarian Cancer Thought Leaders,…
ARIS, FRANCE AND MONTREAL, QUEBEC / ACCESSWIRE / August 28, 2024 / Tribun Health, a leading provider of digital pathology…
MORGANTOWN, W.Va., Aug. 27, 2024 /PRNewswire/ -- The West Virginia University Health System (WVU Medicine) partnered with InVita Healthcare Technologies…
Computer Vision AI and Precision Genomic Collaboration Aims to Increase Early Detection Rates, Improving Survival Chances for Millions DENVER, Aug.…
Bezisterim appears to possess broad homeostatic properties relevant to inflammation and human disorders related to aging Patients treated with bezisterim…
LOS ALTOS, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical…
CAMBRIDGE, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing…
RENO, Nev. and ROCKVILLE, Md., Aug. 23, 2024 /PRNewswire/ -- Melzi Surgical, a medical device company focused on providing innovative technology…
-Validation Studies Confirmed the Assay Can Detect Mpox Clade I and Clade Ib in addition to Clade II- STONY BROOK,…
First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial…